Assuming studies is required, the following results were found.

  • Tecfidera (dimethyl fumarate)

    having a severe allergic reaction to this drug, call 911. Hair loss Hair loss isn't a side effect that has occurred in studies of Tecfidera. However, some people who take Tecfidera have had hair loss. In one report, a woman who started taking Tecfidera...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • Tecfidera (dimethyl fumarate)

    having a severe allergic reaction to this drug, call 911. Hair loss Hair loss isn't a side effect that has occurred in studies of Tecfidera. However, some people who take Tecfidera have had hair loss. In one report, a woman who started taking Tecfidera...

    https://mschristian.org/index.php/articles/2-uncategorised/8434-tecfidera-dimethyl-fumarate
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    leader in neuroscience, today announced positive results for #ofatumumab (OMB157) from the Phase III ASCLEPIOS I and II studies. In both head-to-head studies, ofatumumab demonstrated superiority over Aubagio®* (teriflunomide) in patients with relapsing...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies-1
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    leader in neuroscience, today announced positive results for ofatumumab (OMB157) from the Phase III ASCLEPIOS I and II studies. In both head-to-head studies, ofatumumab demonstrated superiority over Aubagio®* (teriflunomide) in patients with relapsing...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies
  • MS Society-Supported Wellness Research Group Publishes Strategies for Improving Diet Studies in People with MS

    an ideal diet for people with MS? Evidence-based answers to these and other questions require results from well-designed studies. A Wellness Research Group supported by the National MS Society has published new strategies for improving diet studies in...

    https://mschristian.org/index.php/blog/ms-society-supported-wellness-research-group-publishes-strategies-for-improving-diet-studies-in-people-with-ms
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    leader in neuroscience, today announced positive results for #ofatumumab (OMB157) from the Phase III ASCLEPIOS I and II studies. In both head-to-head studies, ofatumumab demonstrated superiority over Aubagio®* (teriflunomide) in patients with relapsing...

    https://mschristian.org/index.php/articles/2-uncategorised/8790-novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies-1
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    leader in neuroscience, today announced positive results for ofatumumab (OMB157) from the Phase III ASCLEPIOS I and II studies. In both head-to-head studies, ofatumumab demonstrated superiority over Aubagio®* (teriflunomide) in patients with relapsing...

    https://mschristian.org/index.php/articles/2-uncategorised/8616-novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies
  • To stay younger for longer, make this change to your diet - Haaretz

    a method of nutrition that can increase one’s life expectancy by 30 percent, as has already been seen in hundreds of studies on animals? Moreover, what if scientists could show that this method not only facilitates weight loss but improves cognitive...

    https://mschristian.org/index.php/blog/to-stay-younger-for-longer-make-this-change-to-your-diet-haaretz
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    multiple sclerosis (2, 3). IFNα/β also demonstrates considerable potential for toxicity, which became apparent in initial studies in rodents (4) and subsequent clinical experience in patients (5, 6). Thus, the production of and response to type I IFNs...

    https://mschristian.org/index.php/blog/severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Fooling nerve cells into acting normal

    Discovery could inform future studies related to spinal cord injuries, multiple sclerosis and epilepsy Date:Source:University of Missouri-ColumbiaSummary:Scientists have discovered that a neuron's own electrical signal, or voltage, can indicate whether...

    https://mschristian.org/index.php/blog/fooling-nerve-cells-into-acting-normal
  • Research on immune activity in MS

    to axons (the wire-like nerve fibers) that contributes to longer-term disability. Research on the immune system includes studies on:Understanding components of the immune system such as T cells, B cells, and antibodiesIdentifying new targets for...

    https://mschristian.org/index.php/blog/research-on-immune-activity-in-ms
  • Coronavirus Outbreak: Daily Updates

    because there’s no other option, and there’s a theoretical reason in the moment that it works.” Researchers say more studies are needed to determine if receiving plasma helped effectively treat people with COVID-19. Share on PinterestCOVID-19 cases are...

    https://mschristian.org/index.php/coronavirus-outbreak-daily-updates
  • Benefits of Tai Chi for Multiple Sclerosis

    beyond your abilities, but does encourage you to explore the edges of your comfort zones. How Does Tai Chi Help MS? Several studies have examined the effect of Tai Chi on different aspects of living with MS and its symptoms. In a systematic review of...

    https://mschristian.org/index.php/benefits-of-tai-chi-for-multiple-sclerosis
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    multiple sclerosis (2, 3). IFNα/β also demonstrates considerable potential for toxicity, which became apparent in initial studies in rodents (4) and subsequent clinical experience in patients (5, 6). Thus, the production of and response to type I IFNs...

    https://mschristian.org/index.php/articles/2-uncategorised/9542-severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Vitamin D: Giveth to Those Who Needeth.

    include or exclude. Indeed, the authors excluded RCTs with combined vitamin D and calcium supplementation, included futile studies of very short duration, or studies with high bolus doses known to transiently increase fracture risk. The best available...

    https://mschristian.org/index.php/blog/vitamin-d-giveth-to-those-who-needeth
  • New insights into how immune system and inflammation play a role in PD

    periphery, particularly in the gastrointestinal tract. Taken together, all data, including human, animal, and microbiome studies, suggest quite strongly that individuals with an increased tendency for peripheral inflammation have a higher risk to...

    https://mschristian.org/index.php/blog/new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd
  • Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

    Methods We measured NfL in blood samples from 589 patients with relapsing-remitting multiple sclerosis (from phase 3 studies of fingolimod vs placebo, FREEDOMS and interferon [IFN]-β-1a, TRANSFORMS) and 35 healthy controls and compared NfL levels with...

    https://mschristian.org/index.php/blog/blood-neurofilament-light-chain-as-a-biomarker-of-ms-disease-activity-and-treatment-response
  • Aubagio (teriflunomide)

    didn't worsen as quickly) a lower risk for new lesions (scar tissue) in the brain For specific information from these studies, see the "Aubagio uses" section. Aubagio generic Aubagio is currently available only as a brand-name medication. Aubagio...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • Aubagio (teriflunomide)

    didn't worsen as quickly) a lower risk for new lesions (scar tissue) in the brain For specific information from these studies, see the "Aubagio uses" section. Aubagio generic Aubagio is currently available only as a brand-name medication. Aubagio...

    https://mschristian.org/index.php/articles/2-uncategorised/8433-aubagio-teriflunomide
  • Genmab A/S (GMAB) Detailed Results from Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing MS Presented at ECTRIMS - StreetInsider.com

    to access https://www.streetinsider.com/Corporate News/Genmab AS (GMAB) Detailed Results from Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing MS Presented at ECTRIMS/15912802.html from 204.152.211.44 on 2019-09-15 15:49:39...

    https://mschristian.org/index.php/articles/2-uncategorised/8602-genmab-a-s-gmab-detailed-results-from-phase-iii-asclepios-i-ii-studies-of-ofatumumab-in-patients-with-relapsing-ms-presented-at-ectrims-streetinsider-com

Results 1 - 20 of 331